Genentech Presents Latest Data on Emicizumab (ACE910)

Note: The below is an edited version of an article originally published on BusinessWire.  The original article can be read in their entirety here.The latest data from an ongoing Japanese Phase I/II study of Emicizumab were presented earlier this week at the World Federation of Hemophilia 2016 World Congress.  Emicizumab (a product being developed by Chugai […]

Intern Introspective: That's a Wrap for Eric

Earlier this summer we welcomed our summer policy & government relations interns to our DC office. Eric and Cami are part of the bleeding disorders community and were chosen to participate in a 10-week internship because of their leadership qualities and interest in the field of policy and advocacy. Throughout the summer, Eric and Cami […]